136 related articles for article (PubMed ID: 22016510)
1. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes.
Tafreshi NK; Bui MM; Bishop K; Lloyd MC; Enkemann SA; Lopez AS; Abrahams D; Carter BW; Vagner J; Grobmyer SR; Gillies RJ; Morse DL
Clin Cancer Res; 2012 Jan; 18(1):207-19. PubMed ID: 22016510
[TBL] [Abstract][Full Text] [Related]
2. A mammaglobin-A targeting agent for noninvasive detection of breast cancer metastasis in lymph nodes.
Tafreshi NK; Enkemann SA; Bui MM; Lloyd MC; Abrahams D; Huynh AS; Kim J; Grobmyer SR; Carter WB; Vagner J; Gillies RJ; Morse DL
Cancer Res; 2011 Feb; 71(3):1050-9. PubMed ID: 21169406
[TBL] [Abstract][Full Text] [Related]
3. Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer.
Lee S; Shin HJ; Han IO; Hong EK; Park SY; Roh JW; Shin KH; Kim TH; Kim JY
Cancer Sci; 2007 Mar; 98(3):329-33. PubMed ID: 17233814
[TBL] [Abstract][Full Text] [Related]
4. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging.
de Gouw DJJM; Rijpkema M; de Bitter TJJ; Baart VM; Sier CFM; Hernot S; van Dam GM; Nagtegaal ID; Klarenbeek BR; Rosman C; van der Post RS
Mol Diagn Ther; 2020 Apr; 24(2):191-200. PubMed ID: 32048177
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase XII functions in health and disease.
Waheed A; Sly WS
Gene; 2017 Aug; 623():33-40. PubMed ID: 28433659
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive Imaging of CD206-Positive M2 Macrophages as an Early Biomarker for Post-Chemotherapy Tumor Relapse and Lymph Node Metastasis.
Zhang C; Yu X; Gao L; Zhao Y; Lai J; Lu D; Bao R; Jia B; Zhong L; Wang F; Liu Z
Theranostics; 2017; 7(17):4276-4288. PubMed ID: 29158825
[TBL] [Abstract][Full Text] [Related]
7. NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Theurillat JP; Zürrer-Härdi U; Varga Z; Storz M; Probst-Hensch NM; Seifert B; Fehr MK; Fink D; Ferrone S; Pestalozzi B; Jungbluth AA; Chen YT; Jäger D; Knuth A; Moch H
Cancer Immunol Immunother; 2007 Nov; 56(11):1723-31. PubMed ID: 17410359
[TBL] [Abstract][Full Text] [Related]
8. High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX.
Žvinys G; Petrosiute A; Zakšauskas A; Zubrienė A; Ščerbavičienė A; Kalnina Z; Čapkauskaitė E; Juozapaitienė V; Mickevičiu Tė A; Shubin K; Grincevičienė Š; Raišys S; Tars K; Matulienė J; Matulis D
Bioconjug Chem; 2024 May; ():. PubMed ID: 38750635
[TBL] [Abstract][Full Text] [Related]
9. Potential of fluorescent metalloproteinase substrates for cancer detection.
Roy R; Zurakowski D; Pories S; Moss ML; Moses MA
Clin Biochem; 2011 Dec; 44(17-18):1434-9. PubMed ID: 22001071
[TBL] [Abstract][Full Text] [Related]
10. Protein alterations in infiltrating ductal carcinomas of the breast as detected by nonequilibrium pH gradient electrophoresis and mass spectrometry.
Kabbage M; Chahed K; Hamrita B; Guillier CL; Trimeche M; Remadi S; Hoebeke J; Chouchane L
J Biomed Biotechnol; 2008; 2008():564127. PubMed ID: 18401453
[TBL] [Abstract][Full Text] [Related]
11. Multiplexed fluorescence imaging of tumor biomarkers in gene expression and protein levels for personalized and predictive medicine.
Smith MQ; Staley CA; Kooby DA; Styblo T; Wood WC; Yang L
Curr Mol Med; 2009 Nov; 9(8):1017-23. PubMed ID: 19747113
[TBL] [Abstract][Full Text] [Related]
12. MIM-CyCIF: masked imaging modeling for enhancing cyclic immunofluorescence (CyCIF) with panel reduction and imputation.
Sims Z; Mills GB; Chang YH
Commun Biol; 2024 Apr; 7(1):409. PubMed ID: 38570598
[TBL] [Abstract][Full Text] [Related]
13. Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.
Chen LQ; Howison CM; Spier C; Stopeck AT; Malm SW; Pagel MD; Baker AF
Leuk Lymphoma; 2015 May; 56(5):1432-9. PubMed ID: 25130478
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
Pastorek J; Pastorekova S
Semin Cancer Biol; 2015 Apr; 31():52-64. PubMed ID: 25117006
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.
Wong BC; Zhang H; Qin L; Chen H; Fang C; Lu A; Yang Z
Drug Des Devel Ther; 2014; 8():993-1001. PubMed ID: 25092965
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases.
Tafreshi NK; Lloyd MC; Bui MM; Gillies RJ; Morse DL
Subcell Biochem; 2014; 75():221-54. PubMed ID: 24146382
[TBL] [Abstract][Full Text] [Related]
17. The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis.
Shamis SAK; Edwards J; McMillan DC
Diagn Pathol; 2023 Apr; 18(1):46. PubMed ID: 37061698
[TBL] [Abstract][Full Text] [Related]
18. Promise of hypoxia-targeted tracers in metastatic lymph node imaging.
Goel S; Shi S
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4293-4297. PubMed ID: 35994060
[No Abstract] [Full Text] [Related]
19. Carbonic anhydrase IX stratifies patient prognosis and identifies nodal status in animal models of nasopharyngeal carcinoma using a targeted imaging strategy.
Huang W; Wang K; Huang W; He Z; Zhang J; Zhang B; Xiong Z; Gillen KM; Li W; Chen F; Yang X; Zhang S; Tian J
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4427-4439. PubMed ID: 35925443
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs and Cancer Resolution: New Paradigms beyond Cyclooxygenase.
Kolawole OR; Kashfi K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
